multicenter randomized Phase

Related by string. * Multicenter : multicenter Phase II . multicenter randomized double . Multicenter Randomized Double / randomizing . randomizer . Randomized : randomized controlled trial . randomized controlled trials . randomized placebo controlled / phases . Phases . phase : Phase III clinical trials . Phase III trials . Phase III clinical * multicenter randomized Phase III *

Related by context. Frequent words. (Click for all words.) 70 phase IIa 67 Amrubicin 67 phase 2a 67 Phase IIa clinical 67 phase IIb 66 Pivotal Phase 66 Phase III 66 Phase 1b 66 Phase IIa trial 66 Phase 2b study 65 Phase 2a trial 65 Phase 2a 65 Pivotal Phase III 65 Phase Ib 64 Phase 2a clinical 64 Phase 1b clinical 63 Phase IIa 63 Phase 2b clinical 63 Phase II 63 Phase 2b trial 63 dose escalation trial 63 Phase IIb clinical 63 Phase III clinical 62 pivotal Phase III 62 Phase 2b 62 Phase Ia 62 Phase IIb 62 pivotal Phase 62 randomized Phase III 61 Phase 1a 61 randomized Phase 61 Pivotal Trial 60 SPIRIT III 60 Pirfenidone 60 multicenter randomized 60 Phase 1b trial 60 axitinib 60 confirmatory Phase III 60 SWOG 60 placebo controlled clinical 59 registrational 59 multicenter clinical 59 Clinical Trial Results 59 Phase III randomized 59 Phase III Trial 59 Phase III pivotal 59 IIa clinical trial 59 HER2 positive metastatic breast 59 Phase 59 BAY #-# 59 ocrelizumab 59 relapsed refractory multiple myeloma 58 label multicenter 58 double blinded placebo 58 ASA# 58 RADIANT 58 Phenoptin 58 tesmilifene 58 INCB# [002] 58 rNAPc2 58 Pharmacokinetic 58 multicentre 58 alvimopan 58 Phase IIb trial 58 DURATION 57 romidepsin 57 dose cohorts 57 eltrombopag 57 IMC A# 57 MDV# 57 multicenter randomized double 57 confirmatory Phase 3 57 CR# vcMMAE 57 NSABP 57 placebo controlled randomized 57 multicenter 57 ATTRACT 57 ZYBRESTAT 56 glufosfamide 56 HGS ETR1 56 aflibercept 56 multiple ascending dose 56 tanespimycin 56 metastatic renal cell carcinoma 56 TRITON TIMI 56 Opexa 56 Initiates Phase 56 J Clin Oncol 56 tocilizumab 56 relapsing remitting multiple sclerosis 56 active comparator 56 PF # [001] 55 ozarelix 55 GVAX 55 PROPEL 55 methylnaltrexone 55 dose escalation study 55 randomized controlled clinical 55 sapacitabine 55 HuMax CD# 55 ISIS #

Back to home page